Every material Form 8-K Copley Acquisition Corp has filed with the SEC since October 13, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Copley Acquisition Corp's shareholders approved extending the deadline to complete a business combination from November 2, 2026 to November 2, 2027, with up to 12 monthly extensions. Holders of 12,889,720 Class A shares redeemed for about $137.1 million, leaving about $46.2 million in the trust account, which matters to shareholders because it reduces the cash backing the remaining shares.
Holders of 12,889,720 Class A shares redeemed at about $10.63 per share, an aggregate of about $137,119,390.16
About $46,241,913.77 remains in the Trust Account and 4,550,280 Class A ordinary shares remain outstanding
Each monthly extension requires a $200,000 deposit into the Trust Account; the first extension runs to December 2, 2026
Sponsor issued an unsecured, non-interest-bearing $2,400,000 promissory note; the vote was 14,428,832 for and 7,101,879 against
Copley Acquisition Corp has moved its extraordinary general meeting from October 29 to November 2, 2026, to seek shareholder approval of an extension of its deadline to complete a business combination by up to 12 one-month periods, through November 2, 2027. The sponsor raised its contribution to the trust account from $150,000 to $200,000 per monthly extension, and the company waived its right to withdraw up to $100,000 of trust interest for dissolution expenses and interest for tax expenses, which the filing says is meant to give holders who voted against the proposals time to reverse their votes.
Meeting adjourned from 11:00 a.m. Eastern on October 29, 2026, to 11:00 a.m. Eastern on November 2, 2026.
Proposed extension allows up to 12 monthly extensions, from November 2, 2026, to November 2, 2027.
Sponsor's contribution per one-month extension revised from $150,000 to $200,000.
Company waived its right to withdraw up to $100,000 of trust interest for dissolution expenses and interest for tax expenses.
Copley Acquisition Corp and Ignite Proteomics mutually agreed on October 9, 2026 to terminate their June 10, 2026 Business Combination Agreement. Copley says it intends to keep pursuing a business combination and has until November 2, 2026 to complete one, subject to extension under its organizational documents.
Business Combination Agreement with Ignite Proteomics, signed June 10, 2026, was terminated by mutual agreement on October 9, 2026.
Each party bears its own expenses, and the agreement includes mutual releases of claims tied to the terminated deal.
Copley's deadline to complete a business combination is November 2, 2026, subject to extension.
Filing warns Copley may have to redeem public shares and liquidate its trust account if it cannot complete another deal.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Copley Acquisition Corp filing is on SEC EDGAR ↗. 8-K briefs of other companies →